PB9415

antibody from Boster Biological Technology

Targeting: ABCG5 STSL

Western blot (Data presented on provider website)

Antibody Data

Product number

PB9415

Provider

Boster Biological Technology

Product name

Anti-ABCG5 Antibody Picoband™

Antibody type

Polyclonal

Description

Polyclonal antibody for ABCG5 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: WB. Reactive species: Human. ABCG5 information: Molecular Weight: 72504 MW; Subcellular Localization: Membrane ; Multi-pass membrane protein ; Tissue Specificity: Strongly expressed in the liver, lower levels in the small intestine and colon.

Reactivity

Human

Host

Rabbit

Vial size

100μg/vial

Concentration

Add 0.2ml of distilled water will yield a concentration of 500ug/ml.

Storage

At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.

Handling

Add 0.2ml of distilled water will yield a concentration of 500ug/ml.

References

Submitted references

Hif-1α expression targets the TMA/Fmo3/TMAO axis to participate in gallbladder cholesterol stone formation in individuals living in plateau regions.

Luo M, Chen P, Tian Y, Rigzin N, Sonam J, Shang F, Tai C, Li T, Sang H
Biochimica et biophysica acta. Molecular basis of disease 2024 Jun;1870(5):167188

---

QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver.

Wang TT, Yang CY, Peng L, Li L, Chen NT, Feng X, Xie J, Wu TC, Xu T, Chen YZ
Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 Jan;123:155192

---

Overexpression of LOX-1 in hepatocytes protects vascular smooth muscle cells from phenotype transformation and wire injury induced carotid neoatherosclerosis through ALOX15.

Zhang Q, Du G, Tong L, Guo X, Wei Y
Biochimica et biophysica acta. Molecular basis of disease 2023 Dec;1869(8):166805

---

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation.

Wang Z, Chen J, Zeng Z, Zhang Q, Du G, Guo X, Wei Y
Molecular medicine (Cambridge, Mass.) 2022 Mar 2;28(1):26